Jayesh Kamath, MD
Psychiatry · Farmington, CTNPI 1982604799
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (48.0%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Johnson & Johnson accounts for 62.4% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $7,814, 7.2 times the $1,092 reported in 2020. Among psychiatry clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 43 payments — averaging $244.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$7K
- Neurocrine Biosciences, Inc.$3K
- Sunovion Pharmaceuticals Inc.$1K
- Novartis$81
Across 202 payments — averaging $6074.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$666K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$296K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$149K
- Novartis$98K
- AbbVie$18K
What the payments were for
- Consulting fees$5,04048%
- Travel & lodging$4,31541%
- Food & beverage$1,15011%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 13 | $6,558 |
| Neurocrine Biosciences, Inc. | 17 | $2,774 |
| Sunovion Pharmaceuticals Inc. | 12 | $1,092 |
| Novartis | 1 | $81 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$6,306
How this compares
$10,504 in reported general payments places this provider in the 90th percentile of 644 psychiatry providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Venlafaxine Hcl ErVenlafaxine Hcl | 35 | $1,151 |
| Gabapentin | 46 | $1,037 |
| Aripiprazole | 12 | $988 |
| Clonazepam | 34 | $670 |
| Quetiapine Fumarate | 29 | $631 |
| Duloxetine Hcl | 19 | $551 |
| Mirtazapine | 19 | $490 |
| Zolpidem Tartrate | 35 | $437 |
| Escitalopram Oxalate | 39 | $409 |
| Olanzapine | 11 | $399 |
| Amitriptyline Hcl | 11 | $397 |
| Bupropion XlBupropion Hcl | 16 | $308 |
| Trazodone Hcl | 51 | $305 |
| Buspirone Hcl | 13 | $285 |
| Lorazepam | 43 | $267 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Farmington
- David MatuskeyFarmington$120K
- Vladimir CoricNew Haven$133.7M
- Donald AmmermanDanbury$1.5M
- Joseph GoldbergNew Canaan$914K
- Lisa HardingMilford$608K
- Tarique PereraDanbury$383K
- John GelinasDanbury$364K
- Irene AbramovichWest Hartford$352K
- Robert BermanNew Haven$126K
- John KrystalWest Haven$122K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.